US Broker Ratings

Health Catalyst, Inc (HCAT) Stock Analysis: Exploring a 78.57% Potential Upside in the Healthcare Data Sector

Health Catalyst, Inc. (NASDAQ: HCAT), a key player in the healthcare information services sector, is garnering attention from investors with its substantial potential upside of 78.57%...

Varex Imaging Corporation (VREX) Stock Analysis: Exploring a 27% Upside Potential

Varex Imaging Corporation (NASDAQ: VREX), a prominent player in the healthcare sector, specializes in the design, manufacture, and sale of X-ray imaging components. With a market..

Viemed Healthcare, Inc. (VMD) Stock Analysis: Unveiling a 60% Upside Potential for Investors

Viemed Healthcare, Inc. (NASDAQ: VMD) stands as a formidable player in the healthcare sector, specifically within the medical devices industry. Known for its innovative respiratory care..

Nano-X Imaging Ltd (NNOX): Investor Outlook on a Promising Healthcare Disruptor with 205% Upside Potential

Nano-X Imaging Ltd (NNOX), a pioneering company in the medical devices sector, is making waves with its innovative approach to tomographic imaging. Headquartered in Petah Tikva,..

Immutep Limited (IMMP) Stock Analysis: Exploring a 251.85% Potential Upside in Biotech Breakthroughs

Immutep Limited (NASDAQ: IMMP) stands out as a significant player in the biotechnology sector with its innovative approach to cancer and autoimmune disease therapies. Based in..

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Promising 66% Upside Potential in Biotech Innovation

For investors eyeing the biotech sector, Entrada Therapeutics, Inc. (NASDAQ: TRDA) presents a compelling opportunity. With a market capitalization of $413.53 million, this Boston-based clinical-stage biopharmaceutical..

Quantum-Si Incorporated (QSI) Stock Analysis: Unveiling a 160% Potential Upside in the Medical Device Sector

Quantum-Si Incorporated (NASDAQ: QSI), a trailblazer in the healthcare sector with a focus on medical devices, is making waves with its cutting-edge technology in Next Generation..

Senseonics Holdings, Inc. (SENS) Stock Analysis: Exploring a 161.64% Potential Upside in the Medical Devices Sector

Senseonics Holdings, Inc. (SENS), a pioneering player in the healthcare sector, has captured the attention of investors with its innovative approach to diabetes management. Specializing in..

Anbio Biotechnology (NNNN) Stock Analysis: Navigating Challenges with Global Reach in Rapid Diagnostics

Anbio Biotechnology (NNNN), a burgeoning player in the healthcare sector, stands at the intersection of innovation and market volatility. With a current market capitalization of $1.01..

Cidara Therapeutics (CDTX) Investor Outlook: Navigating the Biotech Frontier with Minimal Upside

Cidara Therapeutics, Inc. (NASDAQ: CDTX) is a biotech firm that stands at the cutting edge of healthcare innovation, focusing on targeted therapies for serious diseases, including..

UroGen Pharma Ltd. (URGN) Stock Analysis: Unveiling a 70% Upside Potential in Biotechnology

For investors seeking opportunities in the biotechnology sector, UroGen Pharma Ltd. (NASDAQ: URGN) stands out as a compelling candidate. With its focus on developing innovative treatments..

Exxon Mobil (XOM) Stock Analysis: Navigating Market Challenges with Strong Dividend Yield

Exxon Mobil Corporation (NYSE: XOM), a titan in the Energy sector, is a heavyweight in the Oil & Gas Integrated industry, commanding a significant market presence..

Zhengye Biotechnology Holding L (ZYBT): An Investor Outlook on its Market Position and Challenges

Zhengye Biotechnology Holding L (ZYBT) stands at a critical juncture, capturing the attention of investors with its positioning in the healthcare sector, specifically in the niche..

Alpha Teknova, Inc. (TKNO) Stock Analysis: A Healthcare Gem with 291% Potential Upside

For investors with a keen eye on the healthcare sector, Alpha Teknova, Inc. (NASDAQ: TKNO) presents a compelling narrative. This specialty and generic drug manufacturer, based..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a 64.80% Potential Upside

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) has emerged as a notable player in the biotechnology industry, capturing investor interest with an impressive potential upside of 64.80%. Headquartered..

Viridian Therapeutics (VRDN) Stock Analysis: Exploring a Promising 26% Upside with Strong Buy Ratings

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company dedicated to the development of treatments for serious and rare diseases, is capturing the attention of investors with..

AdaptHealth Corp. (AHCO) Stock Analysis: A 32% Upside Awaits Investors in the Home Medical Equipment Sector

AdaptHealth Corp. (NASDAQ: AHCO) is strategically positioned in the healthcare sector, specifically within the medical devices industry. Specializing in the distribution of home medical equipment (HME)..

Artivion, Inc. (AORT) Investor Outlook: Potential Upside of 25.43% and Strong Buy Ratings

Artivion, Inc. (NYSE: AORT), a prominent player in the healthcare sector, specifically within the medical devices industry, is capturing investor attention with a noteworthy potential upside..

Harrow, Inc. (HROW) Stock Analysis: Strong Buy Ratings and a 57% Potential Upside

Harrow, Inc. (NASDAQ: HROW), a growing player in the healthcare sector, is making waves in the pharmaceutical industry, particularly in the realm of ophthalmic solutions. With..

Amphastar Pharmaceuticals (AMPH): Investor Outlook with 13% Potential Upside

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) stands as an intriguing prospect within the healthcare sector, particularly in the niche of specialty and generic drug manufacturing. With a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds